Agency Business briefs: September 2012

Share this article:
Reyn Archer
Reyn Archer

Miami-based JeffreyGroup won a com­petitive pitch to lead a Pfizer public health campaign in Latin America, PR Week reported. The unbranded effort is set to launch in the fall.

The Core Nation said agencies Brandkarma and Core-Create merged under the Brandkarma banner. The Core-Create name is gone, in favor of the name of the younger office, started five years ago.

Johnson & Johnson is consolidating ad creative, Ad Age reported. The review follows Michael Sneed's January appointment as VP corporate affairs, and Alex Gorsky's installment as CEO in April.

PR firm Burson-Marsteller launched a healthcare subsidiary, Consitor, with offices in Zurich and Washington, DC. Dr. Reyn Archer, managing director and chief medical officer in the Burson's US healthcare practice, will lead the DC office. Services include strategy development, brand life cycle management, KOL development, scientific communications, health economics, policy, advocacy and market access.

HCB Health was named agency of record for Austin-based Sanova Dermatology, a provider of medical, surgical and cosmetic skin care.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets